Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01274182
What this trial is testing

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

Who this might be right for
Rheumatoid Arthritis
Sandoz 312
Early research (Phase 1)Study completedNCT06665425
What this trial is testing

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
JW Pharmaceutical 18
Early research (Phase 1)UnknownNCT01201278
What this trial is testing

PK/PD Study of Intranasal Insulin in Type I Diabetes

Who this might be right for
Type 1 Diabetes
Hompesch, Marcus, M.D. 20
Early research (Phase 1)Study completedNCT00988325
What this trial is testing

A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection

Who this might be right for
Influenza
Hoffmann-La Roche 65
Early research (Phase 1)UnknownNCT02462031
What this trial is testing

To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects

Who this might be right for
Obesity
Kwang Dong Pharmaceutical co., ltd. 38
Early research (Phase 1)Study completedNCT03815695
What this trial is testing

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Who this might be right for
Healthy VolunteersSickle Cell Disease
Forma Therapeutics, Inc. 130
Early research (Phase 1)Study completedNCT04224857
What this trial is testing

SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101

Who this might be right for
Ulcerative Colitis
Applied Molecular Transport 52
Early research (Phase 1)UnknownNCT04175704
What this trial is testing

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
United BioPharma 32
Early research (Phase 1)Study completedNCT02361138
What this trial is testing

The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT04775706
What this trial is testing

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Who this might be right for
Short Bowel Syndrome
Hanmi Pharmaceutical Company Limited 18
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Testing effectiveness (Phase 2)Study completedNCT07752810
What this trial is testing

Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout

Who this might be right for
Gout
Hangzhou Grand Biologic Pharmaceutical, Inc. 90
Early research (Phase 1)Study completedNCT00481117
What this trial is testing

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 37
Early research (Phase 1)Study completedNCT02070939
What this trial is testing

Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

Who this might be right for
Healthy
Pfizer 72
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Early research (Phase 1)Study completedNCT05827653
What this trial is testing

MAD Study of NX210c

Who this might be right for
Healthy Elderly
Axoltis Pharma 29
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Early research (Phase 1)Study completedNCT03815396
What this trial is testing

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin DeficiencyAATD
Inhibrx Biosciences, Inc 31
Testing effectiveness (Phase 2)Study completedNCT02956746
What this trial is testing

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines

Who this might be right for
Human Rabies
Synermore Biologics Co., Ltd. 164
Next Page